Related Experiment Video
Updated: Apr 23, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Metronomic maintenance chemotherapy in patients presenting with paraneoplastic autoimmune hepatitis with recurrent
Derya Kivrak Salim1, Hasan Mutlu2, Melek Karakurt Eryilmaz2
1Department of Medical Oncology, Akdeniz University School of Medicine, Antalya, Turkey deryakivrak@gmail.com.
Abstract:
Autoimmune hepatitis is a rarely seen autoimmune paraneoplastic syndrome of thymic carcinoma. Chemotherapy may be an effective choice in the treatment of primary tumor and paraneoplastic disorder. In this case, we report a 32-year-old man presented with increased liver enzymes and cholestasis with a history of thymoma surgically removed four years ago. Liver biopsy showed chronic active autoimmune hepatitis. Computed tomography scan showed pulmonary metastases and pleural mass as a recurrence of thymic carcinoma, proven by biopsy. After four cycles of cisplatin plus adriamycin plus cyclophosphamide plus vincristine and six cycles of paclitaxel plus gemcitabine, maintenance metronomic cyclophosphamide plus etoposide regimen was offered to the patient. Complete biological signs of hepatitis without need for steroids or immune suppressors and complete radiologic response in primary tumor were achieved. Maintenance metronomic chemotherapy regimens may be an alternative to the current treatment options in patients with thymic carcinomas.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Tumor Immunotherapy
Myocarditis IV: Nursing Management
Targeted Cancer Therapies
There are several types of targeted therapies against...
Hyperthyroidism II: Pathophysiology
Treatment Resistant Cancers

